Figure 2: PAS positive yeast-like organism with high magnification (PAS, x100).
Case 2
A 29-year-old woman presented at 20 weeks gestation with
increasing vaginal bleeding over a 2-day period. She had had
an uncomplicated pregnancy until 19 weeks of gestation.
At that time cerclage was performed because of cervical insufficiency. However, she developed preterm premature
rupture of membranes and eventually delivered a stillbirth
fetus at 21 weeks gestation. At autopsy, examination of
stillbirth revealed normal growth and no malformations.
The placenta weighed 200 g and histologically placental
membranes revealed a severe polymorphous infiltrate.
There were large sheets and multiple colonies of yeast-like
microorganisms of variable size which stained positively
with periodic acid-Schiff (Figure 3, 4). C. glabrata was
cultured from both the excised umbilical cord and cervical
cerclage material. The histological features in conjunction
with the positive cultures enabled C. glabrata to be
identified as the causative organism producing the severe
chorioamnionitis.
Figure 4: PAS positive yeast-like organism with high magnification (PAS, x100).
The fetal membranes most often become infected as a result of ascending infection from the vagina. Fungal infections are the rare cause of chorioamnionitis and congenital infections, and most of them are the result of C. albicans infection[1-3]. C. albicans is the most common yeast isolated from the vagina in both symptomatic and asymptomatic patients, followed by C. glabrata and then by other uncommon species[7]. Although C. glabrata has been considered saprophyte of the normal flora of the healthy individuals, it can cause mucosal (oropharyngeal, esophageal, vaginal) or systemic infections in immunocompromised hosts[4-7].
Laboratory experiments have demonstrated that C. albicans can readily infect and invade the fetal membranes in both blastospore and hyphal forms, although other Candida species studied, including C. glabrata, were not able to do so in vitro[8]. Our report clearly demonstrates the ability of C. glabrata to cause a severe chorioamnionitis resulting in poor outcome. Intrauterine infection of this degree indicates that the infective process commenced from within the uterus rather than by the ascending route and this then raises the question as to how this microorganism could have gained access to the uterine cavity if haematogenous spread is excluded.
Candida albicans has been most commonly implicated, often in association with predisposing factors such as an intrauterine device or cervical cerclage[9,10]. Intrauterine yeast infection has also been diagnosed by amniocentesis when pregnancy is complicated by preterm labour or preterm rupture of the membranes. Microbial invasion of the amniotic cavity occurs frequently in women presenting with cervical dilatation in the midtrimester, and the amniotic cavity should therefore be considered before a cerclage is placed in women presenting with cervical dilatation in the midtrimester[10].
Foreign intrauterine bodies such as contraceptive devices and cerclage sutures necessitate repetitive search for Candida species infection, and prompt adequate antifungal treatment in cases of documented infection. In addition, vaginal and in particular cervical swabs should be taken prior to insertion of any cannula into the uterus for embryo transfer. If any pathogens are detected, the procedure should be deferred until treatment has been instituted and the micro-organism eradicated.
1) Tita AT, Andrews WW: Diagnosis and management of clinical chorioamnionitis. Clin Perinatol 2010, 37:339-354 [ Özet ]
2) Roqué H, Abdelhak Y, Young BK: Intra amniotic candidiasis. Case report and meta-analysis of 54 cases. J Perinat Med 1999, 27:253-262 [ Özet ]
3) Barth T, Broscheit J, Bussen S, Dietl J: Maternal sepsis and intrauterine fetal death resulting from Candida tropicalis chorioamnionitis in a woman with a retained intrauterine contraceptive device. Acta Obstet Gynecol Scand 2002, 81:981-982 [ Özet ]
4) Sfameni SF, Talbot JM, Chow SL, Brenton LA, Scurry JP: Candida glabrata chorioamnionitis following in vitro fertilization and embryo transfer. Aust NZ J Obstet Gynaecol 1997, 37:88-91 [ Özet ]
5) Fidel PL Jr, Vazquez JA, Sobel JD: Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 1999, 12:80-96 [ Özet ]
6) Ibara AS, Marcorelles P, Le Martelot MT, Touffet N, Moalic E, Hery-Arnaud G, Giroux JD, Le Flohic AM: Two cases of systemic Candida glabrata infection following in vitro fertilization and embryo transfer. Eur J Clin Microbiol Infect Dis 2004, 23:53-56 [ Özet ]
7) Khan ZU, Ahmad S, Al-Obaid I, Al-Sweih NA, Joseph L, Farhat D: Emergence of resistance to amphotericin B and triazoles in Candida glabrata vaginal isolates in a case of recurrent vaginitis. J Chemother 2008, 20:488-491 [ Özet ]
8) Gurgan T, Diker KS, Haziroglu R, Urman B, Akan M: In vitro infection of human fetal membranes with Candida species. Gynecol Obstet Invest 1994, 37:164-167 [ Özet ]
9) Horn LC, Nenoff P, Ziegert M, Hockel M: Missed abortion complicated by Candida infection in a woman with rested IUD. Arch Gynecol Obstet 2001, 264:215-217 [ Özet ]
10) Romero R, Gonzalez R, Sepulveda W, Brandt F, Ramirez M, Sorokin Y, Mazor M, Treadwell MC, Cotton DB: Infection and labor. VIII. Microbial invasion of the amniotic cavity in patients with suspected cervical incompetence: prevalence and clinical significance. Am J Obstet Gynecol 1992,167:1086-1091 [ Özet ]